News | Page 5 | Loda Lab

Dr. Rodrigues presented her research at the New York Prostate Club

June 11, 2024

Our postdoctoral associate, Dr. Silvia Daniele Rodrigues, presented her work during a meeting of the New York Prostate Club on June 5, 2024. In her talk, titled "Disrupting ELOVL5 Function Impairs Prostate Cancer Progression in c-Myc-driven Mouse Models", Dr. Rodrigues discussed about her crucial work to understand the interplay between lipogenesis, lipid elongation and prostate cancer progression. To this end, Dr. Rodrigues generated genetically engineered mouse models (GEMM) with deletion...

Lipids and DNA damage in prostate cancer - paper alert!

April 18, 2024

Androgen deprivation therapy (ADT) is the primary treatment for prostate cancer, but resistance often develops, leading to CRPC. FASN, the main enzyme of de novo lipogenesis, is overexpressed in prostate cancer cells, and drives the synthesis of fatty acids, fueling cancer growth. Our newest publication, “Blocking lipid synthesis induces DNA damage in prostate cancer and increases cell death caused...

Loda Lab participates at the AACR 2024 Annual Meeting

April 16, 2024

Researchers from the Loda Lab made a significant impact at the 2024 Annual Meeting of the American Association for Cancer Research (AACR), held in San Diego (US). The team not only presented cutting-edge research, but also engaged in valuable networking with fellow scientists.

The AACR Annual Meeting is one of the largest and most influential gatherings in the field, dedicated to advancing cancer research to benefit patients. "Our participation at AACR 2024 allowed us to share...